165 related articles for article (PubMed ID: 15584971)
1. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
[TBL] [Abstract][Full Text] [Related]
2. Characterization of proteoglycans and glycosaminoglycans in splenic AA amyloid induced in mink.
Wien TN; Omtvedt LA; Landsverk T; Husby G
Scand J Immunol; 2000 Dec; 52(6):576-83. PubMed ID: 11119263
[TBL] [Abstract][Full Text] [Related]
3. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
Sørby R; Espenes A; Landsverk T; Westermark G
Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
[TBL] [Abstract][Full Text] [Related]
5. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
Ailles L; Kisilevsky R; Young ID
Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
[TBL] [Abstract][Full Text] [Related]
6. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
7. Splenic ellipsoids: an early target for deposition of AA amyloid induced in mink.
Wien TN; Sørby R; Espenes A; Gunnes G; Nordstoga K; Landsverk T; Husby G
Amyloid; 2003 Dec; 10(4):240-9. PubMed ID: 14986483
[TBL] [Abstract][Full Text] [Related]
8. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis.
Snow AD; Kisilevsky R; Stephens C; Anastassiades T
Lab Invest; 1987 Jun; 56(6):665-75. PubMed ID: 3599910
[TBL] [Abstract][Full Text] [Related]
10. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
Snow AD; Kisilevsky R
Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
[TBL] [Abstract][Full Text] [Related]
11. In vivo analysis of murine serum sulfate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis.
Lyon AW; Anastassiades T; Kisilevsky R
J Rheumatol; 1993 Jul; 20(7):1108-13. PubMed ID: 8371201
[TBL] [Abstract][Full Text] [Related]
12. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
[TBL] [Abstract][Full Text] [Related]
13. Presence and role of glycosaminoglycans in amyloidosis.
Linker A; Carney HC
Lab Invest; 1987 Sep; 57(3):297-305. PubMed ID: 3626519
[TBL] [Abstract][Full Text] [Related]
14. High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts.
Chen CP; Chang SC; Vivian Yang WC
Placenta; 2007; 28(2-3):97-106. PubMed ID: 16630654
[TBL] [Abstract][Full Text] [Related]
15. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
Stenstad T; Magnus JH; Husby G
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
[TBL] [Abstract][Full Text] [Related]
16. Characterization of proteoglycans and glycosaminoglycans in bovine renal AA-type amyloidosis.
Niewold TA; Flores Landeira JM; van den Heuvel LP; Ultee A; Tooten PC; Veerkamp JH
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):321-8. PubMed ID: 1685039
[TBL] [Abstract][Full Text] [Related]
17. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
18. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate proteoglycans in amyloidosis.
Zhang X; Li JP
Prog Mol Biol Transl Sci; 2010; 93():309-34. PubMed ID: 20807650
[TBL] [Abstract][Full Text] [Related]
20. Proteoglycan expression patterns in human hair follicle.
Malgouries S; Thibaut S; Bernard BA
Br J Dermatol; 2008 Feb; 158(2):234-42. PubMed ID: 18067481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
